|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ZURICH, March 27, 2025 (GLOBE NEWSWIRE) -- The $XPL Presale is Now Live, and wallet activity shows that the smartest money in crypto is already securing early positions.

The $XPL presale has now commenced, and early data shows that some of the smartest money in crypto is already securing early positions.
With real AI technology, trading utility, and first-mover status on XRPL, this could be the 100x opportunity XRP holders have been waiting for.
But is the hype real, or are we looking at another overhyped DeFi token? Let’s take a look.
Why There’s So Much Buzz Around XploraDEX
While most DEXs are still struggling to keep up, XploraDEX is forging ahead with:
This isn’t just another DeFi protocol. It’s a next-gen platform designed for performance, speed, and scalability—all powered by AI and coming to XRPL.
GET $XPL TOKEN NOW
The $XPL Token: Unlocking Value & Ecosystem Access
The $XPL Token is the key to everything inside the XploraDEX ecosystem, including:
And with a whale wallet already accumulating a massive 100 billion $XPL tokens, early participants are positioning themselves ahead of what could become XRPL’s most explosive DeFi launch.
$XPL PreSale Token Economic Information
Token Name: XploraDEX
Total Supply: 500,000,000
Presale Allocation: First Come, First Serve!
DEX Listing Price: 25% Higher
Liquidity Pools: Launching immediately after TGE!
Join the XploraDEX AI Revolution Now
The window to claim $XPL tokens at presale pricing is closing rapidly. Early investors who act now will enjoy:
XploraDEX isn’t just launching a new token; it’s bringing an AI-driven trading revolution to the XRP Ledger.
If you missed XRP’s last bull run, this is your second chance—with AI, automation, and whale momentum on your side.
The future of trading is intelligent, fast, and built on XRPL. That future is called XploraDEX.
Join the $XPL Presale Today: https://sale.xploradex.io
Stay updated and Join the XploraDEX AI Revolution
Website | $XPL Token Presale | X | Telegram
Contact: Oliver Muller oliver@xploradex.iocontact@xploradex.io
This press release may contain forward-looking statements. These statements are based on current expectations and assumptions and are subject to known and unknown risks and uncertainties. Readers are cautioned not to place undue reliance on these statements.
izoOm
Disclaimer:info@kdj.com
The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!
If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.
-
-
- Datavecta Forges Global Community Ecosystem to Power International Growth Through Advanced SEO Strategy
- Sep 30, 2026 at 07:55 pm
- Datavecta is building a global community ecosystem to enhance international growth, leveraging advanced SEO strategies and technology-driven services for a connected intelligent trading future.
-
- Illinois Rolls Out Draft Rules for 0.2% Crypto Transaction Tax, Set for 2027
- Sep 30, 2026 at 12:05 pm
- Illinois unveils draft regulations for its upcoming 0.2% digital asset transaction tax, impacting exchanges, transfers, and custody services starting January 1, 2027. The tax applies to the gross value of transactions, not investment gains.
-
-
- Apeing Leads the Charge: Unveiling the Next 100x Crypto Watchlist and 6 Coins to Eye
- Sep 30, 2026 at 12:03 pm
- Amidst a dynamic crypto market, Apeing's presale momentum, coupled with established players like Solana and TRON, is redefining the 100x crypto narrative, offering both early-stage opportunities and proven network strength.
-
-
- OpenAI Unveils GPT-6.1 Sol and Ultrafast Tier, While AstraZeneca Invests Big in Summit Therapeutics
- Sep 30, 2026 at 08:05 am
- OpenAI rolls out GPT-6.1 Sol, offering near-Astra performance at a fraction of the cost, alongside a new 'Ultrafast' speed tier. Meanwhile, AstraZeneca makes a significant $2 billion investment in oncology firm Summit Therapeutics.
-
-
































